Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A rapid assessment of take-home naloxone provision during COVID-19 in Europe.

Autor: McDonald R; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: Rebecca.mcdonald@medisin.uio.no., Eide D; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway., Abel-Ollo K; Drug Abuse and Infectious Diseases Prevention Centre, National Institute for Health Development, Tallinn, Estonia., Barnsdale L; Public Health Scotland, UK., Carter B; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Clausen T; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway., Day E; Institute for Mental Health, School of Psychology, University of Birmingham, UK., Fonseca F; Addiction Research Group, Neuroscience Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Holmén E; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Stockholm Needle Exchange, Stockholm Centre for Dependency Disorders, Stockholm, Sweden., Horsburgh K; Scottish Drugs Forum, Glasgow, UK., Kelleher M; South London and Maudsley NHS Foundation Trust, London, UK., Kåberg M; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Department of Medicine, Division of Infectious Diseases, Karolinska Institute, Stockholm, Sweden., Ladenhauf M; Caritas Kontaktladen und Streetwork im Drogenbereich, Graz, Austria., McAuley A; Public Health Scotland, UK; School of Health and Life Sciences, Glasgow Caledonian University, UK., Metrebian N; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Neale J; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Parkin S; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Ratcliffe K; Change Grow Live, Birmingham, UK., Rintoul C; Cranstoun, Esher, UK., Smith J; Substance Misuse Programme, Public Health Wales, Cardiff, UK., Stifanoviciute V; Drug, Tobacco and Alcohol Control Department, Lithuania., Torrens M; Addiction Research Group, Neuroscience Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Thiesen H; Health Team for the Homeless, Center for Marginalized Adults and Families, Copenhagen City Social Services, Denmark., Strang J; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK.

Publikováno v: The International journal on drug policy [Int J Drug Policy] 2022 Sep; Vol. 107, pp. 103787. Date of Electronic Publication: 2022 Jul 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach.

Autor: Xia Q; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, Tas. 7000, Australia., Campbell JA; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, Tas. 7000, Australia., Si L; The George Institute for Global Health, UNSW Sydney, Kensington, NSW 2042, Australia., Ahmad H; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, Tas. 7000, Australia., de Graaff B; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, Tas. 7000, Australia., Ratcliffe K; Tasmanian Department of Health, Tasmanian State Government, 22 Elizabeth Street, Hobart, Tas. 7000, Australia., Turtle J; Tasmanian Department of Health, Tasmanian State Government, 22 Elizabeth Street, Hobart, Tas. 7000, Australia., Marrone J; Tasmanian Department of Health, Tasmanian State Government, 22 Elizabeth Street, Hobart, Tas. 7000, Australia., Kuzminov A; Department of Surgery, Royal Hobart Hospital, 48 Liverpool Street, Hobart, Tas. 7000, Australia., Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, Tas. 7000, Australia.

Publikováno v: Australian health review : a publication of the Australian Hospital Association [Aust Health Rev] 2022 Feb; Vol. 46 (1), pp. 42-51.

In vitro effects of vandetanib on VEGFR2, EGFR and RET phosphorylation, endothelial cell tube formation, and tumor cell growth and survival

Autor: Brave, SR, Marshall, G, Wainwright, A, James, N, Acheson, N, Howard, Z, Ratcliffe, K, Speake, G, Barry, ST, Hickinson, DM, Ryan, AJ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::40ede8ead0b60261adb3d2cb12324cf1
https://ora.ox.ac.uk/objects/uuid:23556f58-1f9f-4e4b-8b4d-8036af8f397d